Male Hypogonadism Therapy Market - Global Outlook and Forecast 2024-2031

Report ID: 1566824 | Published Date: Jan 2025 | No. of Page: 102 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Male Hypogonadism Therapy Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Male Hypogonadism Therapy Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Male Hypogonadism Therapy Overall Market Size
    2.1 Global Male Hypogonadism Therapy Market Size: 2021 VS 2028
    2.2 Global Male Hypogonadism Therapy Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Male Hypogonadism Therapy Players in Global Market
    3.2 Top Global Male Hypogonadism Therapy Companies Ranked by Revenue
    3.3 Global Male Hypogonadism Therapy Revenue by Companies
    3.4 Top 3 and Top 5 Male Hypogonadism Therapy Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Male Hypogonadism Therapy Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Male Hypogonadism Therapy Players in Global Market
        3.6.1 List of Global Tier 1 Male Hypogonadism Therapy Companies
        3.6.2 List of Global Tier 2 and Tier 3 Male Hypogonadism Therapy Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Male Hypogonadism Therapy Market Size Markets, 2021 & 2028
        4.1.2 Parenteral
        4.1.3 Transdermal
        4.1.4 Oral
        4.1.5 Others
    4.2 By Type - Global Male Hypogonadism Therapy Revenue & Forecasts
        4.2.1 By Type - Global Male Hypogonadism Therapy Revenue, 2017-2022
        4.2.2 By Type - Global Male Hypogonadism Therapy Revenue, 2023-2028
        4.2.3 By Type - Global Male Hypogonadism Therapy Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Male Hypogonadism Therapy Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Drugstores
        5.1.4 Others
    5.2 By Application - Global Male Hypogonadism Therapy Revenue & Forecasts
        5.2.1 By Application - Global Male Hypogonadism Therapy Revenue, 2017-2022
        5.2.2 By Application - Global Male Hypogonadism Therapy Revenue, 2023-2028
        5.2.3 By Application - Global Male Hypogonadism Therapy Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Male Hypogonadism Therapy Market Size, 2021 & 2028
    6.2 By Region - Global Male Hypogonadism Therapy Revenue & Forecasts
        6.2.1 By Region - Global Male Hypogonadism Therapy Revenue, 2017-2022
        6.2.2 By Region - Global Male Hypogonadism Therapy Revenue, 2023-2028
        6.2.3 By Region - Global Male Hypogonadism Therapy Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Male Hypogonadism Therapy Revenue, 2017-2028
        6.3.2 US Male Hypogonadism Therapy Market Size, 2017-2028
        6.3.3 Canada Male Hypogonadism Therapy Market Size, 2017-2028
        6.3.4 Mexico Male Hypogonadism Therapy Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Male Hypogonadism Therapy Revenue, 2017-2028
        6.4.2 Germany Male Hypogonadism Therapy Market Size, 2017-2028
        6.4.3 France Male Hypogonadism Therapy Market Size, 2017-2028
        6.4.4 U.K. Male Hypogonadism Therapy Market Size, 2017-2028
        6.4.5 Italy Male Hypogonadism Therapy Market Size, 2017-2028
        6.4.6 Russia Male Hypogonadism Therapy Market Size, 2017-2028
        6.4.7 Nordic Countries Male Hypogonadism Therapy Market Size, 2017-2028
        6.4.8 Benelux Male Hypogonadism Therapy Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Male Hypogonadism Therapy Revenue, 2017-2028
        6.5.2 China Male Hypogonadism Therapy Market Size, 2017-2028
        6.5.3 Japan Male Hypogonadism Therapy Market Size, 2017-2028
        6.5.4 South Korea Male Hypogonadism Therapy Market Size, 2017-2028
        6.5.5 Southeast Asia Male Hypogonadism Therapy Market Size, 2017-2028
        6.5.6 India Male Hypogonadism Therapy Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Male Hypogonadism Therapy Revenue, 2017-2028
        6.6.2 Brazil Male Hypogonadism Therapy Market Size, 2017-2028
        6.6.3 Argentina Male Hypogonadism Therapy Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Male Hypogonadism Therapy Revenue, 2017-2028
        6.7.2 Turkey Male Hypogonadism Therapy Market Size, 2017-2028
        6.7.3 Israel Male Hypogonadism Therapy Market Size, 2017-2028
        6.7.4 Saudi Arabia Male Hypogonadism Therapy Market Size, 2017-2028
        6.7.5 UAE Male Hypogonadism Therapy Market Size, 2017-2028
7 Players Profiles
    7.1 Eli Lilly
        7.1.1 Eli Lilly Corporate Summary
        7.1.2 Eli Lilly Business Overview
        7.1.3 Eli Lilly Male Hypogonadism Therapy Major Product Offerings
        7.1.4 Eli Lilly Male Hypogonadism Therapy Revenue in Global Market (2017-2022)
        7.1.5 Eli Lilly Key News
    7.2 Pfizer
        7.2.1 Pfizer Corporate Summary
        7.2.2 Pfizer Business Overview
        7.2.3 Pfizer Male Hypogonadism Therapy Major Product Offerings
        7.2.4 Pfizer Male Hypogonadism Therapy Revenue in Global Market (2017-2022)
        7.2.5 Pfizer Key News
    7.3 AbbVie
        7.3.1 AbbVie Corporate Summary
        7.3.2 AbbVie Business Overview
        7.3.3 AbbVie Male Hypogonadism Therapy Major Product Offerings
        7.3.4 AbbVie Male Hypogonadism Therapy Revenue in Global Market (2017-2022)
        7.3.5 AbbVie Key News
    7.4 Novo Nordisk
        7.4.1 Novo Nordisk Corporate Summary
        7.4.2 Novo Nordisk Business Overview
        7.4.3 Novo Nordisk Male Hypogonadism Therapy Major Product Offerings
        7.4.4 Novo Nordisk Male Hypogonadism Therapy Revenue in Global Market (2017-2022)
        7.4.5 Novo Nordisk Key News
    7.5 Merck KGaA
        7.5.1 Merck KGaA Corporate Summary
        7.5.2 Merck KGaA Business Overview
        7.5.3 Merck KGaA Male Hypogonadism Therapy Major Product Offerings
        7.5.4 Merck KGaA Male Hypogonadism Therapy Revenue in Global Market (2017-2022)
        7.5.5 Merck KGaA Key News
    7.6 Mylan
        7.6.1 Mylan Corporate Summary
        7.6.2 Mylan Business Overview
        7.6.3 Mylan Male Hypogonadism Therapy Major Product Offerings
        7.6.4 Mylan Male Hypogonadism Therapy Revenue in Global Market (2017-2022)
        7.6.5 Mylan Key News
    7.7 Bayer
        7.7.1 Bayer Corporate Summary
        7.7.2 Bayer Business Overview
        7.7.3 Bayer Male Hypogonadism Therapy Major Product Offerings
        7.7.4 Bayer Male Hypogonadism Therapy Revenue in Global Market (2017-2022)
        7.7.5 Bayer Key News
    7.8 Teva
        7.8.1 Teva Corporate Summary
        7.8.2 Teva Business Overview
        7.8.3 Teva Male Hypogonadism Therapy Major Product Offerings
        7.8.4 Teva Male Hypogonadism Therapy Revenue in Global Market (2017-2022)
        7.8.5 Teva Key News
    7.9 Novartis
        7.9.1 Novartis Corporate Summary
        7.9.2 Novartis Business Overview
        7.9.3 Novartis Male Hypogonadism Therapy Major Product Offerings
        7.9.4 Novartis Male Hypogonadism Therapy Revenue in Global Market (2017-2022)
        7.9.5 Novartis Key News
    7.10 Abbott
        7.10.1 Abbott Corporate Summary
        7.10.2 Abbott Business Overview
        7.10.3 Abbott Male Hypogonadism Therapy Major Product Offerings
        7.10.4 Abbott Male Hypogonadism Therapy Revenue in Global Market (2017-2022)
        7.10.5 Abbott Key News
    7.11 Roche
        7.11.1 Roche Corporate Summary
        7.11.2 Roche Business Overview
        7.11.3 Roche Male Hypogonadism Therapy Major Product Offerings
        7.11.4 Roche Male Hypogonadism Therapy Revenue in Global Market (2017-2022)
        7.11.5 Roche Key News
    7.12 Endo International
        7.12.1 Endo International Corporate Summary
        7.12.2 Endo International Business Overview
        7.12.3 Endo International Male Hypogonadism Therapy Major Product Offerings
        7.12.4 Endo International Male Hypogonadism Therapy Revenue in Global Market (2017-2022)
        7.12.5 Endo International Key News
    7.13 Ipsen
        7.13.1 Ipsen Corporate Summary
        7.13.2 Ipsen Business Overview
        7.13.3 Ipsen Male Hypogonadism Therapy Major Product Offerings
        7.13.4 Ipsen Male Hypogonadism Therapy Revenue in Global Market (2017-2022)
        7.13.5 Ipsen Key News
    7.14 ANI Pharmaceuticals
        7.14.1 ANI Pharmaceuticals Corporate Summary
        7.14.2 ANI Pharmaceuticals Business Overview
        7.14.3 ANI Pharmaceuticals Male Hypogonadism Therapy Major Product Offerings
        7.14.4 ANI Pharmaceuticals Male Hypogonadism Therapy Revenue in Global Market (2017-2022)
        7.14.5 ANI Pharmaceuticals Key News
    7.15 TherapeuticsMD
        7.15.1 TherapeuticsMD Corporate Summary
        7.15.2 TherapeuticsMD Business Overview
        7.15.3 TherapeuticsMD Male Hypogonadism Therapy Major Product Offerings
        7.15.4 TherapeuticsMD Male Hypogonadism Therapy Revenue in Global Market (2017-2022)
        7.15.5 TherapeuticsMD Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Male Hypogonadism Therapy Market Opportunities & Trends in Global Market
    Table 2. Male Hypogonadism Therapy Market Drivers in Global Market
    Table 3. Male Hypogonadism Therapy Market Restraints in Global Market
    Table 4. Key Players of Male Hypogonadism Therapy in Global Market
    Table 5. Top Male Hypogonadism Therapy Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Male Hypogonadism Therapy Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Male Hypogonadism Therapy Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Male Hypogonadism Therapy Product Type
    Table 9. List of Global Tier 1 Male Hypogonadism Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Male Hypogonadism Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Male Hypogonadism Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Male Hypogonadism Therapy Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Male Hypogonadism Therapy Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Male Hypogonadism Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Male Hypogonadism Therapy Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Male Hypogonadism Therapy Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Male Hypogonadism Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Male Hypogonadism Therapy Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Male Hypogonadism Therapy Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Male Hypogonadism Therapy Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Male Hypogonadism Therapy Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Male Hypogonadism Therapy Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Male Hypogonadism Therapy Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Male Hypogonadism Therapy Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Male Hypogonadism Therapy Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Male Hypogonadism Therapy Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Male Hypogonadism Therapy Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Male Hypogonadism Therapy Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Male Hypogonadism Therapy Revenue, (US$, Mn), 2023-2028
    Table 30. Eli Lilly Corporate Summary
    Table 31. Eli Lilly Male Hypogonadism Therapy Product Offerings
    Table 32. Eli Lilly Male Hypogonadism Therapy Revenue (US$, Mn), (2017-2022)
    Table 33. Pfizer Corporate Summary
    Table 34. Pfizer Male Hypogonadism Therapy Product Offerings
    Table 35. Pfizer Male Hypogonadism Therapy Revenue (US$, Mn), (2017-2022)
    Table 36. AbbVie Corporate Summary
    Table 37. AbbVie Male Hypogonadism Therapy Product Offerings
    Table 38. AbbVie Male Hypogonadism Therapy Revenue (US$, Mn), (2017-2022)
    Table 39. Novo Nordisk Corporate Summary
    Table 40. Novo Nordisk Male Hypogonadism Therapy Product Offerings
    Table 41. Novo Nordisk Male Hypogonadism Therapy Revenue (US$, Mn), (2017-2022)
    Table 42. Merck KGaA Corporate Summary
    Table 43. Merck KGaA Male Hypogonadism Therapy Product Offerings
    Table 44. Merck KGaA Male Hypogonadism Therapy Revenue (US$, Mn), (2017-2022)
    Table 45. Mylan Corporate Summary
    Table 46. Mylan Male Hypogonadism Therapy Product Offerings
    Table 47. Mylan Male Hypogonadism Therapy Revenue (US$, Mn), (2017-2022)
    Table 48. Bayer Corporate Summary
    Table 49. Bayer Male Hypogonadism Therapy Product Offerings
    Table 50. Bayer Male Hypogonadism Therapy Revenue (US$, Mn), (2017-2022)
    Table 51. Teva Corporate Summary
    Table 52. Teva Male Hypogonadism Therapy Product Offerings
    Table 53. Teva Male Hypogonadism Therapy Revenue (US$, Mn), (2017-2022)
    Table 54. Novartis Corporate Summary
    Table 55. Novartis Male Hypogonadism Therapy Product Offerings
    Table 56. Novartis Male Hypogonadism Therapy Revenue (US$, Mn), (2017-2022)
    Table 57. Abbott Corporate Summary
    Table 58. Abbott Male Hypogonadism Therapy Product Offerings
    Table 59. Abbott Male Hypogonadism Therapy Revenue (US$, Mn), (2017-2022)
    Table 60. Roche Corporate Summary
    Table 61. Roche Male Hypogonadism Therapy Product Offerings
    Table 62. Roche Male Hypogonadism Therapy Revenue (US$, Mn), (2017-2022)
    Table 63. Endo International Corporate Summary
    Table 64. Endo International Male Hypogonadism Therapy Product Offerings
    Table 65. Endo International Male Hypogonadism Therapy Revenue (US$, Mn), (2017-2022)
    Table 66. Ipsen Corporate Summary
    Table 67. Ipsen Male Hypogonadism Therapy Product Offerings
    Table 68. Ipsen Male Hypogonadism Therapy Revenue (US$, Mn), (2017-2022)
    Table 69. ANI Pharmaceuticals Corporate Summary
    Table 70. ANI Pharmaceuticals Male Hypogonadism Therapy Product Offerings
    Table 71. ANI Pharmaceuticals Male Hypogonadism Therapy Revenue (US$, Mn), (2017-2022)
    Table 72. TherapeuticsMD Corporate Summary
    Table 73. TherapeuticsMD Male Hypogonadism Therapy Product Offerings
    Table 74. TherapeuticsMD Male Hypogonadism Therapy Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Male Hypogonadism Therapy Segment by Type in 2021
    Figure 2. Male Hypogonadism Therapy Segment by Application in 2021
    Figure 3. Global Male Hypogonadism Therapy Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Male Hypogonadism Therapy Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Male Hypogonadism Therapy Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Male Hypogonadism Therapy Revenue in 2021
    Figure 8. By Type - Global Male Hypogonadism Therapy Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Male Hypogonadism Therapy Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Male Hypogonadism Therapy Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Male Hypogonadism Therapy Revenue Market Share, 2017-2028
    Figure 12. US Male Hypogonadism Therapy Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Male Hypogonadism Therapy Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Male Hypogonadism Therapy Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Male Hypogonadism Therapy Revenue Market Share, 2017-2028
    Figure 16. Germany Male Hypogonadism Therapy Revenue, (US$, Mn), 2017-2028
    Figure 17. France Male Hypogonadism Therapy Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Male Hypogonadism Therapy Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Male Hypogonadism Therapy Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Male Hypogonadism Therapy Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Male Hypogonadism Therapy Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Male Hypogonadism Therapy Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Male Hypogonadism Therapy Revenue Market Share, 2017-2028
    Figure 24. China Male Hypogonadism Therapy Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Male Hypogonadism Therapy Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Male Hypogonadism Therapy Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Male Hypogonadism Therapy Revenue, (US$, Mn), 2017-2028
    Figure 28. India Male Hypogonadism Therapy Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Male Hypogonadism Therapy Revenue Market Share, 2017-2028
    Figure 30. Brazil Male Hypogonadism Therapy Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Male Hypogonadism Therapy Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Male Hypogonadism Therapy Revenue Market Share, 2017-2028
    Figure 33. Turkey Male Hypogonadism Therapy Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Male Hypogonadism Therapy Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Male Hypogonadism Therapy Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Male Hypogonadism Therapy Revenue, (US$, Mn), 2017-2028
    Figure 37. Eli Lilly Male Hypogonadism Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Pfizer Male Hypogonadism Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. AbbVie Male Hypogonadism Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Novo Nordisk Male Hypogonadism Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Merck KGaA Male Hypogonadism Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Mylan Male Hypogonadism Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Bayer Male Hypogonadism Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Teva Male Hypogonadism Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Novartis Male Hypogonadism Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Abbott Male Hypogonadism Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Roche Male Hypogonadism Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Endo International Male Hypogonadism Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Ipsen Male Hypogonadism Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. ANI Pharmaceuticals Male Hypogonadism Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 51. TherapeuticsMD Male Hypogonadism Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
102
Frequently Asked Questions
Male Hypogonadism Therapy Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Male Hypogonadism Therapy Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Male Hypogonadism Therapy Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports